Intrust Bank Na Supernus Pharmaceuticals, Inc. Transaction History

Intrust Bank Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$30.84 - $49.51 $167,707 - $269,235	-5,438 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$42.7 - $56.55 $106,109 - $140,526	-2,485 Reduced 31.36%	5,438 $274,000
Q2 2018 Aug 08, 2018	BUY	$44.1 - $59.85 $7,011 - $9,516	159 Added 2.05%	7,923 $474,000
Q1 2018 May 03, 2018	BUY	$37.15 - $46.9 $30,128 - $38,035	811 Added 11.66%	7,764 $356,000
Q4 2017 Feb 08, 2018	SELL	$36.4 - $42.6 $145 - $170	-4 Reduced 0.06%	6,953 $277,000

Q3 2017 Nov 06, 2017	BUY	$36.75 - $49.65 $255,669 - $345,415	6,957	6,957 $278,000

260

57.3M

84.1K

61.2K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.4B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

Stay updated on Intrust Bank Na with notifications on news.